| Health / Medical Topics |
Human Papillomavirus Vaccine V503
A vaccine consisting of noninfectious, recombinant virus-like particles (VLP) containing the major viral capsid protein L1 of nine strains of human papillomavirus (HPV), with potential immunoprotective activity. Vaccination with HPV V503 may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells positive for any of these nine strains of HPV, thereby preventing cervical infection upon exposure to certain HPV subtypes. (NCI Thesaurus)
YOU MAY ALSO LIKE
A vaccine used to prevent genital warts, anal cancer, cervical cancer, vulvar cancer, and vaginal cancer caused by certain types of human…
A vaccinia viral based vaccine, encoding epitopes of E6 and E7 proteins from human papillomavirus (HPV) types 16 and 18, with immunostimulatory…
A laboratory test in which cells are tested for DNA or RNA from certain types of human papillomavirus (HPV) that are known…
A laboratory test in which cells are scraped from the cervix to look for RNA of the most common types of human…
A squamous cell carcinoma associated with human papilloma type 16 virus, arising from the oropharynx.
A laboratory test in which cells are scraped from the cervix to look for DNA of human papillomaviruses (HPV). HPV can cause…
